Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05202444Not ApplicableCompleted

The Use of Piezoelectric Surgery for Osteotomies

Role: collaborator

NCT04907955Not ApplicableCompleted

Visual Performance Following Implantation of Presbyopia Correcting IOLs

Role: lead

NCT04904887Not ApplicableUnknown

Clinical Outcomes With a New Monofocal IOL Enhanced for Intermediate Vision

Role: lead

NCT04904874Not ApplicableUnknown

Intense Pulsed Light Therapy in Meibomian Gland Dysfunction

Role: lead

NCT03288116Completed

Objective and Subjective Diagnostic Parameters in the Fellow Eye of Unilateral Keratoconus

Role: lead

NCT03193411Not ApplicableCompleted

Visumax Femtolasik Versus Moria M2 Microkeratome in Myopia

Role: lead

All 6 trials loaded